Acciones Peloton Therapeutics, Inc.
Acciones
PLTX
US70614L1044
Biotecnología e investigación médica
Directores | Puesto | Edad | Desde |
---|---|---|---|
Naseem Zojwalla
CTO | Chief Tech/Sci/R&D Officer | 51 | - |
Corporate Officer/Principal | - | - | |
Peter Stenge
PRN | Corporate Officer/Principal | - | - |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Helen Kim
BRD | Director/Board Member | 61 | 01/11/17 |
Brett A. Ringle
BRD | Director/Board Member | 73 | 01/01/11 |
David Chang
BRD | Director/Board Member | 64 | 01/02/18 |
Varia. 1 de ene. | Capi. | |
---|---|---|
+16,42 % | 122 mil M | |
+19,02 % | 113 mil M | |
+3,00 % | 22,66 mil M | |
-11,63 % | 16,68 mil M | |
-16,15 % | 16,61 mil M | |
-39,57 % | 16,92 mil M | |
+2,68 % | 13,62 mil M | |
+21,16 % | 11,04 mil M | |
+108,78 % | 10,43 mil M |